{
    "medicine_id": "f41680bc7e67d995e24694e2727df575305a99de",
    "platform_id": "DB05296",
    "metadata": {
        "name": "Caprelsa 300 mg Tablet film coated",
        "composition": "300 mg Motexafin lutetium",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in brain cancer breast cancer cervical dysplasia cancer prostate cancer cancer tumors unspecified coronary artery disease macular degeneration and peripheral vascular disease",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00707",
                        "description": "Motexafin lutetium may increase the photosensitizing activities of Porfimer sodium"
                    },
                    {
                        "drugbank-id": "DB00460",
                        "description": "Motexafin lutetium may increase the photosensitizing activities of Verteporfin"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Motexafin lutetium"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}